Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Deloitte
QuintilesIMS
Harvard Business School
Baxter

Generated: August 17, 2019

DrugPatentWatch Database Preview

Litigation Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Docket   Try a Free Trial Date Filed 2018-08-06
Court District Court, W.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To Earl Leroy Yeakel III
Jury Demand Plaintiff Referred To
Parties CUSTOPHARM, INC.; FRESENIUS KABI DEUTSCHLAND GMBH; FRESENIUS KABI USA, LLC
Patents 7,828,787; 8,118,802; 8,162,915
Attorneys Brian P Murray; Cabrach J. Connor; Donald R. McPhail; Gregory D. Fernengel; Ian Scott; Jaimin Hemendra Shah; John T. Bennett; Kevin S. Kudlac; Mark G. Davis; Richard T. Ruzich; Roshan P. Shrestha; Samuel Sherry; Stephen R. Auten; Travis C. Barton
Firms Connor Kudlac Lee PLLC; Fernengel Law, LLC; Goodwin Procter LLP; McGinnis, Lochridge & Kilgore, LLP; Taft Stettinius & Hollister LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Fresenius Kabi USA, LLC v. Custopharm, Inc.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for Fresenius Kabi USA, LLC v. Custopharm, Inc. (W.D. Tex. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 37 Amended Complaint States Patent Nos. 8,118,802 (“the ‘802 patent”), 8,162,915 (“the ‘915 patent”), and 7,828,787 (“the … COUNT III FOR INFRINGEMENT OF U.S. PATENT NO. 7,828,787 66. The allegations of paragraphs… ‘787 patent”) (collectively, “the Patents-in-Suit”). This action arises out of Defendant’s filing of… BACKGROUND The Patents-in-Suit 24. The ‘802 patent, entitled “Connector for packaging…inventors assigned the ‘802 patent to Fresenius Kabi Deutschland GmbH. The ‘802 patent is listed in the Orange External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Army
Merck
Accenture
Farmers Insurance
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.